The Added Value of18F-FDOPA PET/CT in the Work-Up of Patients with Movement Disorders

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Movement disorders represent a common clinical feature in many different neurologic diseases. However, although the clinical features are often similar, there are many different possible etiologies of these movement disorders, which represent a valid diagnostic challenge. Management of these patients is dependent on an accurate diagnosis of the underlying etiology because the clinical course and treatment may vary significantly.18FFluor-L-dopa has been used as a positron-emitting compound for PET evaluation of patients with movement disorders and parkinsonism. To emphasize the diagnostic value of combining both morphologic and functional imaging in18F-Fluor-L-dopa PET/CT, we describe the clinical history and18F-Fluor-L-dopa PET/CT imaging findings of 5 patients in whom the cause of movement impairment was unclear.

Original languageEnglish
Pages (from-to)344-348
Number of pages5
JournalNeurographics
Volume9
Issue number5
DOIs
StatePublished - 1 Oct 2019

Fingerprint

Dive into the research topics of 'The Added Value of18F-FDOPA PET/CT in the Work-Up of Patients with Movement Disorders'. Together they form a unique fingerprint.

Cite this